ALLSCRIPTS HEALTHCARE SO - NOTE 0.875% 1/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q2 2025

Type / Class
Debt / NOTE 0.875% 1/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ALLSCRIPTS HEALTHCARE SO - NOTE 0.875% 1/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2025 Q2 $0 $0 -$44,527,687 0
2025 Q1 $41,146,000 $44,527,687 +$8,116,406 108.22% 1
2024 Q4 $33,646,000 $37,713,187 +$549,765 112.09% 1
2024 Q3 $33,646,000 $37,163,422 -$21,091,284 110.45% 1
2024 Q2 $53,646,000 $58,254,706 -$7,753,079 108.59% 1
2024 Q1 $61,146,000 $63,710,877 -$155,079,969 103.77% 3
2023 Q4 $215,378,000 $217,092,597 -$6,253,635 100.48% 16
2023 Q3 $218,595,000 $247,725,202 +$3,912,667 113.2% 21
2023 Q2 $215,416,000 $239,872,144 -$2,104,721 111.35% 22
2023 Q1 $217,142,000 $245,233,716 -$17,269,757 112.75% 28
2022 Q4 $211,570,000 $302,262,141 +$21,319,874 142.91% 28
2022 Q3 $200,644,000 $256,473,326 +$6,811,016 127.89% 26
2022 Q2 $189,330,000 $239,115,772 -$16,290,981 126.2% 25
2022 Q1 $202,997,000 $357,850,366 +$3,009,202 177.11% 27
2021 Q4 $208,451,000 $307,907,501 -$6,852,260 147.94% 21
2021 Q3 $217,878,000 $258,164,579 +$9,692,124 118.48% 23
2021 Q2 $191,738,000 $286,184,269 -$2,722,194 149.08% 22
2021 Q1 $207,599,000 $274,136,305 +$274,136,305 131.99% 22